Comment from National Center for Health Research

AnonymousOpposeAdvocacy
Summary: The National Center for Health Research (NCHR) opposes the Commissioner’s National Priority Voucher (CNPV) Pilot Program as currently designed, arguing it lacks transparency, scientific rigor, and clear justification over existing expedited pathways. They urge the FDA to discontinue the pilot or make substantial revisions to remove non-scientific criteria like affordability and domestic manufacturing from the selection process.
See attached.

View on Regulations.gov